NCT01435798View on ClinicalTrials.gov

Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan Dose Response Clinical Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Central Neuropathic PainAllodyniaSpinal Cord Injury
Interventions
DRUG

Dextromethorphan

0, 25, 50 and 100% of maximum tolerated dose, each administered over a 4 week period

Trial Locations (1)

02115

Translational Pain Research, Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Brigham and Women's Hospital

OTHER

NCT01435798 - Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan Dose Response Clinical Trial | Biotech Hunter | Biotech Hunter